Joe may have been saying, as you state, that Altucell "has

New Post Public Reply Private Reply Replies (1) Message Board
Buildit Msowid #11769
301
Joe may have been saying, as you state, that Altucell "has the right to go their separate ways if and only if...". Or, as he stated it, "Wrong as usual if you took the time to read it's from when any Govt interaction or delay occurs till that delay is over".

However, the 8-k states:

"If ALTuCELL chooses to cancel the transaction as a result of delays due to forces beyond the control of Generex, including government regulatory delays or extended reviews by regulators that delay approvals of corporate actions... ALTuCELL agrees to return all payments made by Generex."

That is clear as day. They can choose to walk after 30 days if they want, at the sole pain of returning the deposit and operations funding GNBT has given them to that point.

Now, they may INTEND to extend the deal if necessary. But I doubt any legal team would back Joe's implication that the 30 day clock doesn't start ticking until the gov't review are over, at least as far as the 8-k shows us.

And that's the real crux of my point. Yes, Olaregen and others have continued to extend their deals, to-date. And that has been a life saver for GNBT (and us), IMHO. However, everyone has their limits. What would happen if Olaregen decided to walk? Would others follow? We won't know until it happens. But if it happens, it could be disastrous.

Joe has assembled a fine looking ship. But right now, the parts of the ship are held together by rope. Once the div is in the rear view mirror, the S-1 is approved, NGIO spins (pushing up the share price), S-1 funding is received, and Joe pays off the deals and sets the machine to work, the ship will be welded together, and we will be able to get it up to speed.

We know that Joe has a LOT of info in his head that we are not privy to. Maybe he mistakenly bases some of these comments on that type of info. For example, maybe Altucell TOLD JOE that they would not really start the clock until 30 days after the gov't review period is up (or that they intend to keep extending to that point), because they really want to be part of Joe's team. So that could be what Joe thinks when he reads a post like Hylander's. However, public info sometimes is contrary to what Joe insinuates (based on his deeper level of knowledge) when he comes to the boards and lets loose on people.

As I have told Joe here and through PM, he needs to remember that he is stuck with us retail investors until he can get GNBT onto the NAZ. We are not professionals, and this is not our full time job. We make mistakes, we miss things, we forget details from time to time, but we do the best we can to process and keep up with a fluid and complex situation.

In the meantime, it would behoove Joe, again in my opinion, to treat his shareholders with as much respect on the boards as he does on the calls. That means no drive-by heated comments based on a small sampling of posts. He should either participate by understanding whole conversations, respond professionally to comments, and wait around for people to get back to him or not come here at all... especially when he appears to be incorrect, as is the case here, unless he can point to another document.

To that point, I'm still hoping Joe comes back to explain his comment to Hylander and what info he can share with us that backs up his claim...

==============
I did read the 8k, several times. and of course i read your pointing out Joe's explanation, discrepancy wise. And i did go back and reread the 8k. What Joe was referring to, according to my understanding, was Altucel has the right to go their separate ways if and only if (regulatory denials and or a long process, natural disasters and other unforeseen events) the reasons listed hereto. The way i understood it and Joe's explanation, is that they can not cancel because of other reasons and do welcome more extensions, if necessary, to continue with this venture......hence why Joe was so upset (11691)....

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 5

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 3

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 4

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 4

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading

Top 5 Most Recently Viewed Articles

H.C. Wainwright & Co. Dominates Transaction Rankings for 2024

Updated Category News Views 312

H.C. Wainwright & Co. Achieves #1 Ranking in 2024 H.C. Wainwright & Co., LLC, has proudly announced its remarkable achievement as the leading investment bank by transaction volume for the year 2024. This ranking by PlacementTracker highlights their dedication to excellence, allowing them to sustain their top position for an impressive 11 consecutive years. In 2024, H.C....

Continue Reading
TAPP Engine Adds Envestnet Portfolios for Credit Unions

Updated Category News Views 6

Transforming Digital Wealth for Community Banks TAPP Engine's newest collaboration with Envestnet is shaking things up for credit unions and community banks across the United States. Pairing TAPP Engine's robust digital investing platform with Envestnet's active-passive ETF model portfolios, they’re aiming to give these institutions the tools they need to hold tight to...

Continue Reading
Innovative Clinical Trial Aims to Revolutionize Myeloid Cancer Care

Updated Category News Views 163

Innovative Clinical Trial Aims to Revolutionize Myeloid Cancer Care The National Institutes of Health (NIH) has recently initiated a groundbreaking clinical trial designed to explore precision medicine treatments for myeloid cancers, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). This initiative focuses on tailored treatment combinations...

Continue Reading
Comprehensive Updates on Recent Product Recalls by CPSC

Updated Category News Views 106

Stay Informed: Recent Product Recalls by CPSC Recent developments from the U.S. Consumer Product Safety Commission (CPSC) highlight important recalls designed to protect the public from various risks associated with consumer products. Understanding these recalls is critical for ensuring the safety of yourself and your loved ones. Electric Bicycle Recall by TREK TREK has...

Continue Reading
OTR Solutions Enhances Freight Services with Acquisition

Updated Category News Views 235

OTR Solutions Expands Its Freight Financing Operations OTR Solutions has recently made headlines with its strategic acquisition of the TruckSmarter factoring and banking division. This acquisition marks a crucial step forward, reinforcing OTR Solutions' position as a leader in logistics-oriented financial technology and streamlining back-office operations for carriers in...

Continue Reading